The gene mutation related to Nestin expression might have a significant role in the carcinogenesis of ICC and hepatocellular carcinoma mixed tumors and can serve as a biomarker for the diagnosis and prognosis of combined hepatocellular–ICC. The gene discussed is NES; the disease is intrahepatic cholangiocarcinoma.